SEC Comment Letter for ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858) (ACHV) — Mar 12, 2010

ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)
Date: March 12, 2010 · CIK: 0000949858 · Accession: 0000000000-10-013867

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

March 10, 2010

Author

Gus Rodriguez

Form

UPLOAD

Company

ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 March 10, 2010 Stephen Anderson Chief Financial Officer and Secretary OncoGenex Pharmaceuticals, Inc. 1522 217 th Place SE, Suite 100 Bothell, WA 98021

Re: OncoGenex Pharmaceuticals, Inc . Form 10-K for the Fiscal Year Ended December 31, 2008 Definitive Proxy Statement filed on Schedule 14A File Number: 033-80623

Dear Mr. Anderson,

We have completed our review of your Form 10-K and related filings have no further comments at this time. Sincerely,

Gus Rodriguez Accounting Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail
Mail Stop 4720

         March 10, 2010

Stephen Anderson
Chief Financial Officer and Secretary
OncoGenex Pharmaceuticals, Inc.
1522 217
th Place SE, Suite 100
Bothell, WA 98021

Re:    OncoGenex Pharmaceuticals, Inc .
 Form 10-K for the Fiscal Year Ended December 31, 2008
Definitive Proxy Statement filed on Schedule 14A
          File Number:  033-80623

Dear Mr. Anderson,

We have completed our review of your Form 10-K and related filings have no
further comments at this time.
 Sincerely,

Gus Rodriguez
Accounting Branch Chief

SecProbe.io